The evidence shows that the lncRNA SPRY4-IT1 is epigenetically silenced in NSCLC through transcriptional repression mediated by the Polycomb group protein enhancer of zeste homolog 2 (EZH2). The gene discussed is SPRY4; the disease is non-small cell lung carcinoma.